After eight weeks of therapy, the triglycerides and total cholesterol levels in Group R were statistically significantly lower than those in Group C, while the HDL cholesterol level in Group R was statistically significantly higher than in Group C.
From these, adding RE therapy to the standard-of-care was inferred to be effective in improving lipid metabolism in patients with metabolic syndrome.